Related references
Note: Only part of the references are listed.Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokines
Sonia Vicens-Artes et al.
IMMUNOLOGIC RESEARCH (2022)
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
Jean Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
Ranny van Weissenbruch et al.
JOURNAL OF ASTHMA AND ALLERGY (2020)
Current therapeutical strategies for allergic rhinitis
Ludger Klimek et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Increasing Prevalence of Allergic Rhinitis in China
Yuan Zhang et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)
Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia
Natalia I. Ilyina et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management
C. Bachert et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2018)
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision
Jan L. Brozek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China
Hongfei Lou et al.
SCIENTIFIC REPORTS (2017)
An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011
X. D. Wang et al.
ALLERGY (2016)
Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis
William E. Berger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis
Eli Meltzer et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Nasal-Ocular Reflexes and Their Role in the Management of Allergic Rhinoconjunctivitis With Intranasal Steroids
Fuad M Baroody et al.
World Allergy Organization Journal (2013)
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety
Eli O. Meltzer et al.
ALLERGY AND ASTHMA PROCEEDINGS (2012)
Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: The Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study
Belen de la Hoz Caballer et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2012)
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis
Warner Carr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Evaluation of quality of life questionnaires for adult patients with moderate to severe allergic rhinitis
Dan Lu et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2011)
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device
Frank C. Hampel et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet et al.
ALLERGY (2008)
Share Paper
